Main Menu
Main Menu
Menu

BioFect Innovations

by

Overview

BioFect Innovations (Toronto) has designed a microorganism to mass produce a sugar substitute.

What they’re doing: Due to lack of availability, mass production of the sweetener, brazzein, is not currently possible. But through synthetic biology and precision fermentation, BioFect has designed a microorganism that can produce large quantities of brazzein through a method that is economical, efficient and sustainable.

How will this be used in the real world? Along with the potential to replace/reduce the dependence on traditional sugars in many food products, this technology can make brazzein a key ingredient in eco-conscious food and beverage products.

AIMA Laboratories

by

Overview

AIMA Laboratories (Hamilton) is speeding up the diagnosis of endometriosis by creating a home test.

What they’re doing: This FemTech company is focusing on women’s health and providing unique solutions to diagnostic and therapeutic challenges. Endometriosis is one of the leading causes of chronic and debilitating pelvic pain and infertility. Because of ambiguous symptoms and pain normalization, it can take 5-12 years for women with endometriosis to get a diagnosis.

How will this be used in the real world? The first blood test for endometriosis that can be done from the comfort of home to give women and their physicians more clarity and a quicker path to diagnosis!